Hematology - European Medical Journal

Continue

Hematology

Filter
1 Mins
1 Aug 2019

Post-Transplant Cyclophosphamide in HLA Matched and Haploidentical Transplant Recipients Receiving Myeloablative Timed Sequential Busulfan Conditioning Regimen: Results of a Phase II Study

The authors report a prospective Phase II trial to assess (a) if post-transplant cyclophosphamide (PTCy) could be safely incorporated in a timed…
1 Mins
1 Aug 2019

Autologous Dendritic Cell Vaccination to Prevent Progression and Relapse in Multiple Myeloma

Data from the National Cancer Institute showed that 50% of myeloma patients survive past 5 years post-diagnosis. This is encouraging but also warns…
2 Mins
1 Aug 2019

Gilteritinib Plus Azacitidine in Newly Diagnosed FLT3 Mutated (FLT3mut+) Acute Myeloid Leukaemia Patients Ineligible for Intensive Induction Chemotherapy: Preliminary Findings from the Safety Cohort

Search of more effective treatment for patients with acute myeloid leukaemia (AML) who are ineligible for intensive chemotherapy remains challenging…
2 Mins
2 Aug 2018

Polymorphisms in Multidrug Resistance Transporter Genes Affect the Duration of Molecular Response to Nilotinib in Chronic Myeloid Leukaemia Patients

Despite the high efficacy and improved clinical response of nilotinib in chronic myeloid leukaemia (CML), there is still a significant proportion of…
2 Mins
2 Aug 2018

Inherited Platelet Disorders Caused by Thrombopoietin Mutation

Thrombopoietin (THPO) and the interaction with its receptor c-Mpl have a nonredundant role in platelet biogenesis and maintenance of the haematopoietic…
1 Mins
2 Aug 2018

Bacterial Contamination of Platelet Transfusion Units Affects Platelet Haemostatic Function and Immunological Activity

Transfusion-associated bacterial infection is a major risk of platelet transfusion and can be fatal. The storage requirements of platelet concentrates…
2 Mins
2 Aug 2018

Lenalidomide: The Gift That Keeps on Giving

First-line therapy for indolent non-Hodgkin’s lymphoma usually consists of a combination of rituximab-based chemoimmunotherapy. Historically, first-line…
1 Mins
2 Aug 2018

A Targeted Next-Generation Sequencing-Based Diagnosis for Hereditary Anaemias

Anaemia affects 1.6 billion people worldwide, with roughly 10% of these individuals affected by rare anaemias, of which 80% are hereditary. Hereditary…
We’ve noticed you’re accessing
from North/South America.